Lumax Auto Technologies Limited (NSE:LUMAXTECH)

Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	796.49	510.26	746.32	484.08	166.58
Short-Term Investments	1,914	238.11	818.99	897.55	810.93
Trading Asset Securities	-	2,500	966.65	689.74	403.49
Cash & Short-Term Investments	2,710	3,249	2,532	2,071	1,381
Cash Growth	-16.57%	28.31%	22.23%	49.99%	20.40%
Accounts Receivable	7,924	5,985	4,877	2,664	2,345
Other Receivables	-	58.2	162.42	24.81	12.13
Receivables	7,941	6,056	5,049	2,695	2,363
Inventory	3,665	2,488	1,611	1,118	835.88
Prepaid Expenses	-	65.09	69.86	25.66	21.63
Other Current Assets	1,640	1,320	591.13	386.63	265.9
Total Current Assets	15,956	13,178	9,853	6,296	4,867
Property, Plant & Equipment	8,759	7,354	6,905	4,033	3,690
Long-Term Investments	1,983	1,637	1,124	530.29	904.26
Goodwill	1,757	936.55	1,219	1.66	1.66
Other Intangible Assets	3,109	1,978	2,164	50.86	33.31
Long-Term Deferred Tax Assets	39	24.42	57.74	0.78	0.85
Other Long-Term Assets	782.13	874.07	519.97	472.22	398.35
Total Assets	32,391	25,988	21,848	11,389	9,897
Accounts Payable	6,859	4,858	3,840	2,310	2,048
Accrued Expenses	348.51	703.6	767.63	497.52	423.98
Short-Term Debt	-	2,695	1,449	1,088	468.45
Current Portion of Long-Term Debt	4,269	891.62	126.47	55.31	200.06
Current Portion of Leases	243.62	187.58	169.26	73.56	73.44
Current Income Taxes Payable	76.75	2.25	56.39	6.12	26.71
Other Current Liabilities	2,407	1,767	1,150	667.23	499.54
Total Current Liabilities	14,203	11,105	7,558	4,698	3,740
Long-Term Debt	3,415	3,217	3,947	102.29	55.24
Long-Term Leases	1,094	1,109	949.6	331.12	186.83
Long-Term Deferred Tax Liabilities	635.35	277.55	793.44	141.67	140.58
Other Long-Term Liabilities	29.87	27.15	24.91	-	-
Total Liabilities	19,459	15,855	13,361	5,342	4,186
Common Stock	136.32	136.32	136.32	136.32	136.32
Additional Paid-In Capital	-	452.86	452.86	452.86	452.86
Retained Earnings	-	6,244	5,203	4,521	4,027
Comprehensive Income & Other	9,210	1,063	823.72	329.34	690.59
Total Common Equity	9,347	7,896	6,616	5,439	5,307
Minority Interest	3,585	2,237	1,871	607.74	403.66
Shareholders' Equity	12,932	10,133	8,487	6,047	5,711
Total Liabilities & Equity	32,391	25,988	21,848	11,389	9,897
Total Debt	9,022	8,099	6,641	1,650	984.01
Net Cash (Debt)	-6,311	-4,850	-4,109	421.32	396.99
Net Cash Growth	-	-	-	6.13%	-
Net Cash Per Share	-92.59	-71.16	-60.29	6.18	5.82
Filing Date Shares Outstanding	68.12	68.16	68.16	68.16	68.16
Total Common Shares Outstanding	68.12	68.16	68.16	68.16	68.16
Working Capital	1,753	2,073	2,295	1,598	1,127
Book Value Per Share	137.21	115.85	97.07	79.80	77.87
Tangible Book Value	4,481	4,982	3,234	5,387	5,272
Tangible Book Value Per Share	65.77	73.09	47.45	79.03	77.35
Land	-	622.11	622.11	321.11	293.63
Buildings	-	1,464	1,398	1,114	1,049
Machinery	-	7,455	6,654	4,481	4,137
Construction In Progress	-	358.49	128.58	121.29	93.29
Leasehold Improvements	-	151.67	138.82	89.8	32.72

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.